rs144982584

Variant summary

Our verdict is Benign. The variant received -15 ACMG points: 0P and 15B. BP4_ModerateBP6_Very_StrongBP7BS2

The NM_173495.3(PTCHD1):​c.657C>T​(p.Asn219Asn) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00262 in 1,210,242 control chromosomes in the GnomAD database, including 3 homozygotes. There are 1,014 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0018 ( 1 hom., 47 hem., cov: 23)
Exomes 𝑓: 0.0027 ( 2 hom. 967 hem. )

Consequence

PTCHD1
NM_173495.3 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 3.01

Publications

0 publications found
Variant links:
Genes affected
PTCHD1 (HGNC:26392): (patched domain containing 1) This gene encodes a membrane protein with a patched domain. The encoded protein is similar to Drosophila proteins which act as receptors for the morphogen sonic hedgehog. Deletions in this gene, which is located on the X chromosome, are associated with intellectual disability and autism (PMID: 21091464, PMID: 20844286). [provided by RefSeq, Aug 2011]
PTCHD1 Gene-Disease associations (from GenCC):
  • autism, susceptibility to, X-linked 4
    Inheritance: XL Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), G2P
  • non-syndromic X-linked intellectual disability
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -15 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.44).
BP6
Variant X-23379896-C-T is Benign according to our data. Variant chrX-23379896-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 195428.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=3.01 with no splicing effect.
BS2
High Hemizygotes in GnomAd4 at 47 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PTCHD1NM_173495.3 linkc.657C>T p.Asn219Asn synonymous_variant Exon 2 of 3 ENST00000379361.5 NP_775766.2
PTCHD1XM_011545449.4 linkc.657C>T p.Asn219Asn synonymous_variant Exon 3 of 4 XP_011543751.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PTCHD1ENST00000379361.5 linkc.657C>T p.Asn219Asn synonymous_variant Exon 2 of 3 1 NM_173495.3 ENSP00000368666.4
PTCHD1ENST00000456522.1 linkc.157-12635C>T intron_variant Intron 1 of 1 1 ENSP00000406663.1

Frequencies

GnomAD3 genomes
AF:
0.00176
AC:
198
AN:
112196
Hom.:
1
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.000551
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000753
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000376
Gnomad FIN
AF:
0.00229
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00293
Gnomad OTH
AF:
0.00132
GnomAD2 exomes
AF:
0.00189
AC:
347
AN:
183471
AF XY:
0.00199
show subpopulations
Gnomad AFR exome
AF:
0.000608
Gnomad AMR exome
AF:
0.000510
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00369
Gnomad NFE exome
AF:
0.00309
Gnomad OTH exome
AF:
0.00132
GnomAD4 exome
AF:
0.00270
AC:
2966
AN:
1097991
Hom.:
2
Cov.:
31
AF XY:
0.00266
AC XY:
967
AN XY:
363347
show subpopulations
African (AFR)
AF:
0.000265
AC:
7
AN:
26398
American (AMR)
AF:
0.000625
AC:
22
AN:
35207
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19383
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30206
South Asian (SAS)
AF:
0.000573
AC:
31
AN:
54143
European-Finnish (FIN)
AF:
0.00375
AC:
152
AN:
40534
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4136
European-Non Finnish (NFE)
AF:
0.00312
AC:
2629
AN:
841898
Other (OTH)
AF:
0.00271
AC:
125
AN:
46086
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
133
267
400
534
667
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
104
208
312
416
520
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00177
AC:
199
AN:
112251
Hom.:
1
Cov.:
23
AF XY:
0.00137
AC XY:
47
AN XY:
34411
show subpopulations
African (AFR)
AF:
0.000549
AC:
17
AN:
30945
American (AMR)
AF:
0.000752
AC:
8
AN:
10643
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2658
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3571
South Asian (SAS)
AF:
0.000753
AC:
2
AN:
2655
European-Finnish (FIN)
AF:
0.00229
AC:
14
AN:
6121
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
219
European-Non Finnish (NFE)
AF:
0.00293
AC:
156
AN:
53215
Other (OTH)
AF:
0.00130
AC:
2
AN:
1538
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
9
19
28
38
47
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00135
Hom.:
9
Bravo
AF:
0.00155
EpiCase
AF:
0.00300
EpiControl
AF:
0.00273

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Jun 12, 2014
Eurofins Ntd Llc (ga)
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Aug 02, 2017
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Apr 16, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dec 31, 2019
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Benign:1
Mar 30, 2017
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.44
CADD
Benign
10
DANN
Benign
0.61
PhyloP100
3.0
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs144982584; hg19: chrX-23398013; API